Pharmacological properties of racemic and optically active p-chloroamphetamine.
D000661:Amphetamine / Q000032:analysis / Q000097:blood / Q000494:pharmacology* / Q000633:toxicity / Q000652:urine; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D001066:Appetite / Q000187:drug effects; D001067:Appetite Depressants / Q000494:pharmacology; D001923:Brain Chemistry; D001933:Brain Stem / Q000032:analysis; D002319:Cardiovascular System / Q000187:drug effects; D002713:Chlorine; D004285:Dogs; D006591:Hexobarbital / Q000494:pharmacology; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000032:analysis; D012890:Sleep / Q000187:drug effects
D000700:Analgesics; D000927:Anticonvulsants; D000928:Antidepressive Agents; D001067:Appetite Depressants; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D002713:Chlorine; D006591:Hexobarbital; D000661:Amphetamine; D009638:Norepinephrine